| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 954.35M | 943.67M | 701.06M | 532.26M | 470.06M |
| Gross Profit | 119.87M | 344.64M | 167.79M | 116.41M | 215.94M |
| EBITDA | 132.76M | 127.84M | 95.55M | 77.61M | 80.33M |
| Net Income | 81.99M | 75.56M | 58.20M | 50.07M | 51.03M |
Balance Sheet | |||||
| Total Assets | 996.89M | 979.95M | 977.74M | 536.79M | 494.24M |
| Cash, Cash Equivalents and Short-Term Investments | 121.44M | 78.35M | 77.48M | 70.82M | 108.25M |
| Total Debt | 20.27M | 80.77M | 84.39M | 59.46M | 65.97M |
| Total Liabilities | 294.43M | 346.55M | 406.35M | 237.74M | 237.25M |
| Stockholders Equity | 701.31M | 631.96M | 569.47M | 299.05M | 256.98M |
Cash Flow | |||||
| Free Cash Flow | 128.46M | 84.44M | 78.67M | 35.36M | 55.23M |
| Operating Cash Flow | 130.77M | 89.28M | 81.77M | 41.15M | 56.34M |
| Investing Cash Flow | -12.72M | -48.74M | -69.02M | -52.73M | -12.48M |
| Financing Cash Flow | -76.10M | -40.18M | -7.41M | -25.85M | -23.96M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | €715.24M | 18.67 | 12.71% | 2.54% | 11.35% | 2.20% | |
75 Outperform | €1.01B | 12.27 | 12.87% | 0.84% | 1.13% | 8.26% | |
69 Neutral | €855.15M | 13.81 | 14.08% | 3.07% | 5.78% | -1.04% | |
66 Neutral | €2.81B | 9.49 | 14.39% | 3.03% | -2.23% | 20.83% | |
64 Neutral | €16.18B | 13.01 | 10.95% | 2.35% | 1.67% | -3.83% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
41 Neutral | €667.94M | -0.49 | 319.82% | ― | -16.46% | 93.72% |